Fact CheckerSign in

NCT05101837CompletedPhase 4

Feasibility and Effectiveness of a Specific App to Delivery Mindfulness Sessions

Feasibility and Effectiveness of a Specific App to Delivery Mindfulness Sessions to Patients with Different Kinds of Pain Condition: a Pilot Study

Source: ClinicalTrials.gov · Last updated 23 Jan 2025

Brief summary (registry, in English)

A standardized behavioural approach based on mindfulness delivered mainly by a specific APP on android will be developed and applied for patients with chronic pain conditions, as migraine and neuropathic pain. The aim of this pilot study: The investigators propose a pilot study to enforce the application of a Home-program for patients with different pain conditions, to learn mindfulness practice, added to a regular mindfulness guided face-to-face program, by using the technology with android to receive mindfulness sessions for daily practice and to assess the feasibility and the effectiveness of behavioural approach base on mindfulness delivered with this modality.

Status (registry)
Completed
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
30 (actual)
First submitted
27 Sept 2021
Start date
20 Nov 2023
Primary completion date
20 Nov 2023
Lead sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Diseases
Migraine
NCT number
NCT05101837

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 30
  • From 20 Nov 2023 to the primary completion date, 20 Nov 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • co-existent severe medical or psychiatric illnesses, documented by specific previous diagnoses

Other illness

  • seizures

Other

  • use of opioids

Who the study is looking for

  • diagnosis of Neuropathic Pain and Chronic Migraine
  • written informed consent

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fondazione IRCCS Istituto Neurologico Carlo Besta
Coordinator of this site? Confirm its status
MilanItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.